RAPT Therapeutics, Inc. (RAPT)

$1.87 6.83% $0.12 Healthcare

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

$65.27M

Dr. Brian Russell Wong M.D., Ph.D.

94.00

South San Francisco, CA

Oct 31, 2019

-0.60

$-3.13

3.25

13.46

-14,746.18%

-5.52

2.61

729.51

13.30

-42.82%

-44.24%

Similar stocks (14)

Arvinas, Inc.

ARVN

$26.31 -6.17%
Downtrend

Relay Therapeutics, Inc.

RLAY

$5.98 -2.92%
Downtrend

Pliant Therapeutics, Inc.

PLRX

$13.91 -4.13%
Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$9.13 -8.79%
Uptrend

Design Therapeutics, Inc.

DSGN

$6.91 4.54%
Uptrend

Eliem Therapeutics, Inc.

ELYM

$5.11 -0.97%
Downtrend

Black Diamond Therapeutics, Inc.

BDTX

$3.24 -4.14%
Downtrend

PepGen Inc.

PEPG

$4.79 -4.01%
Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.15 -2.27%
Downtrend

PMV Pharmaceuticals, Inc.

PMVP

$1.66 -5.41%
Neutral

Ikena Oncology, Inc.

IKNA

$1.76 0.57%
Uptrend

Anebulo Pharmaceuticals, Inc.

ANEB

$1.65 -2.37%
Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 -2.75%
Downtrend

HCW Biologics Inc.

HCWB

$0.32 -16.65%
Downtrend

ETF Exposure (14)

iShares Micro-Cap ETF

IWC

0.01212%

$135.90 -1.91%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.006%

$23.77 -2.42%
Uptrend

iShares Biotechnology ETF

IBB

0.00498%

$144.36 -2.27%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00369%

$177.58 -1.76%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.001821483712846889%

$62.76 -5.40%
Uptrend

iShares Russell 2000 ETF

IWM

0.00172%

$237.36 -1.79%
Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

9.592899999999999e-4%

$59.32 -1.23%
Uptrend

ProShares Hedge Replication ETF

HDG

2.935210293478857e-4%

$50.24 -0.58%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

1.1908e-4%

$69.37 -1.28%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

9.0e-5%

$131.55 -0.45%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

8.372e-5%

$35.93 -0.53%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

6.691e-5%

$41.57 -0.38%
Uptrend

iShares Russell 3000 ETF

IWV

6.0e-5%

$342.01 -0.45%
Uptrend

Dimensional U.S. Equity ETF

DFUS

5.543e-5%

$65.17 -0.40%
Uptrend